SINERGY is delighted to introduce and welcome The Republic Polytechnic, Azenta, and GDMC as it's new Industry Members.
In partnership with Synthetic Biology Australasia, SINERGY organized a webinar on “Bringing synthetic biology to market: an Australia and Singapore perspective” on Tuesday, 2 August 2022. Here you can watch recordings of the startup and investor panel discussions from the webinar, and gain insights into what entrepreneurs and founders from Australia and Singapore had to say.
What is the secret of successful Synthetic Biology company? According to Emily Leproust, CEO of Twist Bioscience, it all depends on people. In this interview, Sierin Lim explores the journey of Emily Leproust as a scientist and entrepreneur, how Twist was made, what motivated her, as well as her advice to aspiring scientists and entrepreneurs in Biotech and Synthetic Biology.
Combining synthetic, computational, and structural biology improves key enzyme in cannabinoid biosynthesisFaheem Kausar2022-05-18T12:58:46+08:00
While cannabis plants are best known for the psychotropic effects of THC, Cannabis sativa contains a wealth of secondary metabolites. Many of these compounds, known under the umbrella term “cannabinoids”, have potential applications as therapeutics.
Julius Fredens is one of the newest members of Singapore’s synbio community. After obtaining his PhD from University of Southern Denmark, he moved to the MRC Laboratory of Molecular Biology in Cambridge to work with Professor Jason Chin on genetic code compression.
To encourage reuse and reproducibility in the synthetic biology community, the National University of Singapore (NUS) Synthetic Biology for Clinical and Technological Innovation (SynCTI) has established SynbioResources, a digital collection of databases and tools related to synthetic biology.
One of the most unexpected food for microbes is carbon-rich gas. LanzaTech, a company founded in New Zealand and based in Illinois, USA, decided to challenge this conventional wisdom. By recycling carbon from...